Literature DB >> 23856839

Chromoblastomycosis in Australia: an historical perspective.

David Weedon1, Mitchell van Deurse, Scott Allison, Cliff Rosendahl.   

Abstract

AIMS: To study the histological features of a large series of patients with chromoblastomycosis to ascertain whether the earlier presentation of patients with this disease has resulted in any changes in the histological features that were recorded over 60 years ago.
METHODS: A key word search of the database of our pathology laboratory over the period 1 January 2004 to 30 June 2012 was carried out for cases reported as chromoblastomycosis.
RESULTS: Seventy cases of chromoblastomycosis were reported over this period. A further four cases of subcutaneous chromomycosis were found in this search. They were excluded from the study because of their different aetiopathogenesis. Key histological features such as the presence of pseudoepitheliomatous hyperplasia, granulomas, suppurative granulomas, suppuration and the presence of brown (dematiaceous) sclerotic bodies were evaluated. Fewer cases showed pseudoepitheliomatous hyperplasia than in earlier studies. Sclerotic bodies were found easily in H&E sections in all cases, averting the need for any special stains. Only ten cases were submitted for culture; six grew Cladophialophora carionii and two Fonsecaea pedrosoi.
CONCLUSIONS: Chromoblastomycosis has changed little, histologically, since the original descriptions over 60 years ago, despite its much earlier clinical presentation these days. Pseudoepitheliomatous hyperplasia was seen in 77.1% of our cases, compared to its almost universal presence in cases reported many years ago that often presented after many years with the disease.

Entities:  

Mesh:

Year:  2013        PMID: 23856839     DOI: 10.1097/PAT.0b013e32836326a1

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  First reported Australian case of Cladophilophora arxii: features consistent with possible primary pulmonary chromoblastomycosis.

Authors:  Anna Brischetto; Sarah Kidd; Rob Baird
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Chromoblastomycosis Caused by Phialophora-Proven Cases from Mexico.

Authors:  Sarah A Ahmed; Alexandro Bonifaz; Gloria M González; Leandro F Moreno; Nickolas Menezes da Silva; Vania A Vicente; Ruoyu Li; Sybren de Hoog
Journal:  J Fungi (Basel)       Date:  2021-01-29

Review 4.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818

5.  Chromoblastomycosis: A case series from Eastern China.

Authors:  Sujun Liu; Huilin Zhi; Hong Shen; Wenwen Lv; Bo Sang; Qiuping Li; Yan Zhong; Zehu Liu; Xiujiao Xia
Journal:  PLoS Negl Trop Dis       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.